1. Home
  2. INBK vs OBIO Comparison

INBK vs OBIO Comparison

Compare INBK & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Internet Bancorp

INBK

First Internet Bancorp

N/A

Current Price

$26.64

Market Cap

231.2M

Sector

Finance

ML Signal

N/A

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$3.98

Market Cap

238.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBK
OBIO
Founded
1999
2017
Country
United States
United States
Employees
355
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.2M
238.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
INBK
OBIO
Price
$26.64
$3.98
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$23.25
$14.25
AVG Volume (30 Days)
26.8K
201.3K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
1.06%
N/A
EPS Growth
N/A
33.13
EPS
N/A
N/A
Revenue
N/A
$33,482,000.00
Revenue This Year
$279.34
N/A
Revenue Next Year
$12.97
$12.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$17.05
$2.20
52 Week High
$28.88
$5.42

Technical Indicators

Market Signals
Indicator
INBK
OBIO
Relative Strength Index (RSI) 59.17 54.66
Support Level $25.23 $3.77
Resistance Level $28.88 $4.18
Average True Range (ATR) 0.91 0.15
MACD -0.02 0.03
Stochastic Oscillator 100.00 95.42

Price Performance

Historical Comparison
INBK
OBIO

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: